| Katherine Cashman Porter, CRNA | |
|
1551 Professional Ln Unit 290, Longmont, CO 80501-6970 | |
| (303) 604-5000 | |
| Not Available |
| Full Name | Katherine Cashman Porter |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 13 Years |
| Location | 1551 Professional Ln Unit 290, Longmont, Colorado |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265799837 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Boulder Valley Gastroenterology Inc. | 4688577174 | 48 |
| Diehl Anesthesia | 6800197575 | 19 |
News Archive
Influenza from birds, commonly known as H5N1 avian flu, has killed at least 306 people during the past seven years and innumerable birds and poultry. Now a team of scientists in Britain have developed a way to breed poultry that are genetically resistant to H5N1 or any other avian flu virus. The study by Scientists from Cambridge and Edinburgh universities was reported in the Jan. 13 issue of Science.
Indiana University School of Medicine researcher Bryan P. Schneider, MD, is leading a novel nationwide study to better understand how to treat patients with triple-negative breast cancer based on their own unique genetic data.
Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced the completion of three MUSE procedures in Italy by renowned gastroenterologist, Professor Pier Alberto Testoni, Director of Gastroenterology and Digestive Endoscopy IRCCS at San Raffaele Hospital in Milan.
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes.
Viking Systems, Inc. announced today that its Next Generation 3DHD Visualization System was presented June 10th at The European Congress of Laparoscopy and Robotics by Dr. Gunter Janetschek, Professor and Chairman, Department of Urology, Medical University Salzburg, as part of his talk "Is there a future beyond 'da Vinci'?"
› Verified 2 days ago
| Entity Name | Boulder Valley Gastroenterology Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902832603 PECOS PAC ID: 4688577174 Enrollment ID: O20040130001035 |
News Archive
Influenza from birds, commonly known as H5N1 avian flu, has killed at least 306 people during the past seven years and innumerable birds and poultry. Now a team of scientists in Britain have developed a way to breed poultry that are genetically resistant to H5N1 or any other avian flu virus. The study by Scientists from Cambridge and Edinburgh universities was reported in the Jan. 13 issue of Science.
Indiana University School of Medicine researcher Bryan P. Schneider, MD, is leading a novel nationwide study to better understand how to treat patients with triple-negative breast cancer based on their own unique genetic data.
Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced the completion of three MUSE procedures in Italy by renowned gastroenterologist, Professor Pier Alberto Testoni, Director of Gastroenterology and Digestive Endoscopy IRCCS at San Raffaele Hospital in Milan.
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes.
Viking Systems, Inc. announced today that its Next Generation 3DHD Visualization System was presented June 10th at The European Congress of Laparoscopy and Robotics by Dr. Gunter Janetschek, Professor and Chairman, Department of Urology, Medical University Salzburg, as part of his talk "Is there a future beyond 'da Vinci'?"
› Verified 2 days ago
| Entity Name | Us Anesthesia Partners Of Colorado Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922365782 PECOS PAC ID: 6002072055 Enrollment ID: O20120725000032 |
News Archive
Influenza from birds, commonly known as H5N1 avian flu, has killed at least 306 people during the past seven years and innumerable birds and poultry. Now a team of scientists in Britain have developed a way to breed poultry that are genetically resistant to H5N1 or any other avian flu virus. The study by Scientists from Cambridge and Edinburgh universities was reported in the Jan. 13 issue of Science.
Indiana University School of Medicine researcher Bryan P. Schneider, MD, is leading a novel nationwide study to better understand how to treat patients with triple-negative breast cancer based on their own unique genetic data.
Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced the completion of three MUSE procedures in Italy by renowned gastroenterologist, Professor Pier Alberto Testoni, Director of Gastroenterology and Digestive Endoscopy IRCCS at San Raffaele Hospital in Milan.
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes.
Viking Systems, Inc. announced today that its Next Generation 3DHD Visualization System was presented June 10th at The European Congress of Laparoscopy and Robotics by Dr. Gunter Janetschek, Professor and Chairman, Department of Urology, Medical University Salzburg, as part of his talk "Is there a future beyond 'da Vinci'?"
› Verified 2 days ago
| Entity Name | Diehl Anesthesia |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467833897 PECOS PAC ID: 6800197575 Enrollment ID: O20151229000111 |
News Archive
Influenza from birds, commonly known as H5N1 avian flu, has killed at least 306 people during the past seven years and innumerable birds and poultry. Now a team of scientists in Britain have developed a way to breed poultry that are genetically resistant to H5N1 or any other avian flu virus. The study by Scientists from Cambridge and Edinburgh universities was reported in the Jan. 13 issue of Science.
Indiana University School of Medicine researcher Bryan P. Schneider, MD, is leading a novel nationwide study to better understand how to treat patients with triple-negative breast cancer based on their own unique genetic data.
Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced the completion of three MUSE procedures in Italy by renowned gastroenterologist, Professor Pier Alberto Testoni, Director of Gastroenterology and Digestive Endoscopy IRCCS at San Raffaele Hospital in Milan.
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes.
Viking Systems, Inc. announced today that its Next Generation 3DHD Visualization System was presented June 10th at The European Congress of Laparoscopy and Robotics by Dr. Gunter Janetschek, Professor and Chairman, Department of Urology, Medical University Salzburg, as part of his talk "Is there a future beyond 'da Vinci'?"
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Cashman Porter, CRNA 1615 Turin Dr, Longmont, CO 80503-2717 Ph: (720) 713-9792 | Katherine Cashman Porter, CRNA 1551 Professional Ln Unit 290, Longmont, CO 80501-6970 Ph: (303) 604-5000 |
News Archive
Influenza from birds, commonly known as H5N1 avian flu, has killed at least 306 people during the past seven years and innumerable birds and poultry. Now a team of scientists in Britain have developed a way to breed poultry that are genetically resistant to H5N1 or any other avian flu virus. The study by Scientists from Cambridge and Edinburgh universities was reported in the Jan. 13 issue of Science.
Indiana University School of Medicine researcher Bryan P. Schneider, MD, is leading a novel nationwide study to better understand how to treat patients with triple-negative breast cancer based on their own unique genetic data.
Medigus Ltd., a medical device company developing minimally invasive endosurgical tools and a leader in direct visualization technology, announced the completion of three MUSE procedures in Italy by renowned gastroenterologist, Professor Pier Alberto Testoni, Director of Gastroenterology and Digestive Endoscopy IRCCS at San Raffaele Hospital in Milan.
The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic myeloid leukemia (CML). However, researchers have stumbled onto another possible use for it, curing type 2 diabetes.
Viking Systems, Inc. announced today that its Next Generation 3DHD Visualization System was presented June 10th at The European Congress of Laparoscopy and Robotics by Dr. Gunter Janetschek, Professor and Chairman, Department of Urology, Medical University Salzburg, as part of his talk "Is there a future beyond 'da Vinci'?"
› Verified 2 days ago
Mark J. Parsons, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1532 Sunset St, Longmont, CO 80501 Phone: 720-494-9325 Fax: 720-494-9325 | |
Joey Peter Martsolf, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1551 Professional Ln, Longmont, CO 80501 Phone: 303-640-5000 | |
Malcolm Joseph Monlezun, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 13601 N 115th St, Longmont, CO 80504 Phone: 303-915-2269 Fax: 866-663-6555 |